SM
Solomon Moshkevich (PRESIDENT, CLINICALDIAGNOSTICS) filed 20 Form 4 reports in the trailing twelve months (0 purchases, 20 sales), most often in Natera, Inc. (NTRA). The largest single filing was $5.9M of NTRA (18,160 sh across 4 lots, as filed), executed Sep 1. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
20
0 buys · 20 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$23.5M
shares × price, as filed
Last traded
Nov 2
Filed Nov 4
Median ADV $454.8M across their filed names
Open performance→Volume by month
Buys $0
Sells $35.7M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
20 filings
Sector per market data · by filing · past 12 months
Most traded names
NTRARecent filings
NTRASALE
Natera, Inc.
View filing →
$135K867 sh × $155.46
Exec Aug 14 2025
Filed Aug 15 2025 · 5:30 PM ET NTRASALE Natera, Inc. View filing → $385K
2,900 sh across 2 lots
Exec Aug 1 2025
Filed Aug 5 2025 · 5:30 PM ET NTRASALE Natera, Inc. View filing → $308K
2,206 sh × $139.81
Exec Jul 28 2025
Filed Jul 30 2025 · 5:30 PM ET NTRASALE Natera, Inc. View filing → $353K
2,109 sh × $167.25
Exec Jul 1 2025
Filed Jul 3 2025 · 5:30 PM ET